Markus Britschgi
Impact in
- Biological Psychiatry top 0.5%
- Tryptophan and brain disorders
- Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological disorders and treatments
Papers in
- Physiology 20
- Alzheimer's disease research and treatments 15
- Asthma and respiratory diseases 5
- Neurology 14
- Parkinson's Disease Mechanisms and Treatments 14
- Neuroinflammation and Neurodegeneration Mechanisms 9
- Neurological disorders and treatments 5
- Co-authors
- Werner J. Pichler (15 shared papers)Tony Wyss‐Coray (11 shared papers)Ramya Narasimhan (3 shared papers)Edward M. Rockenstein (2 shared papers)Eliezer Masliah (2 shared papers)Eric P. M. Prinssen (2 shared papers)Kurt M. Lucin (2 shared papers)Stephen Toovey (2 shared papers)
- Journals
- Molecular Neurodegeneration (2 papers)Journal of Allergy and Clinical Immunology (2 papers)The Journal of Experimental Medicine (2 papers)The Journal of Immunology (2 papers)Clinical & Experimental Allergy (2 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Markus Britschgi
55 papers receiving 8.8k citations
Markus Britschgi's Hit Papers
Peers
Comparison fields: 5 of 154
- Biological Psychiatry 637
- Neurology 1.7k
- Neurology 1.9k
- Developmental Neuroscience 490
- Physiology 2.8k
Countries citing papers authored by Markus Britschgi
This map shows the geographic impact of Markus Britschgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Britschgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Britschgi more than expected).
Fields of papers citing papers by Markus Britschgi
This network shows the impact of papers produced by Markus Britschgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Britschgi. The network helps show where Markus Britschgi may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Britschgi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The ageing systemic milieu negatively regulates neurogenesis and cognitive function Hit paper breakdown → | 2011 | 1449 |
| 2 | The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice Hit paper breakdown → | 2008 | 941 |
| 3 | Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins Hit paper breakdown → | 2007 | 901 |
| 4 | Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes Hit paper breakdown → | 2019 | 728 |
| 5 | Maternal immune activation and abnormal brain development across CNS disorders Hit paper breakdown → | 2014 | 712 |
| 6 | Cryo-EM structure of alpha-synuclein fibrils Hit paper breakdown → | 2018 | 478 |
| 7 | 2001 | 295 | |
| 8 | Trial of Prasinezumab in Early-Stage Parkinson’s Disease Hit paper breakdown → | 2022 | 282 |
| 9 | 2019 | 247 | |
| 10 | 2013 | 199 | |
| 11 | 2003 | 190 | |
| 12 | 2012 | 189 | |
| 13 | 2009 | 171 | |
| 14 | 2004 | 139 | |
| 15 | 2002 | 119 | |
| 16 | 2006 | 116 | |
| 17 | 2002 | 115 | |
| 18 | 2002 | 112 | |
| 19 | 2017 | 105 | |
| 20 | 2005 | 104 |
About Markus Britschgi
Markus Britschgi is a scholar working on Physiology, Neurology, Neurology, Immunology and Pharmacology, having authored 55 papers that have together received 9.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (15 papers), Parkinson's Disease Mechanisms and Treatments (14 papers), Drug-Induced Adverse Reactions (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Immune cells in cancer (5 papers), Neurological disorders and treatments (5 papers), Asthma and respiratory diseases (5 papers) and Tryptophan and brain disorders (4 papers). The work is most often cited by research in Biological Psychiatry (637 citations), Neurology (1.7k citations), Neurology (1.9k citations), Developmental Neuroscience (490 citations) and Physiology (2.8k citations). Markus Britschgi has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Werner J. Pichler, Tony Wyss‐Coray, Ramya Narasimhan, Edward M. Rockenstein, Eliezer Masliah, Eric P. M. Prinssen, Kurt M. Lucin, Stephen Toovey, Laurie Chicha and Scott Schobel. Their work appears in journals such as Molecular Neurodegeneration, Journal of Allergy and Clinical Immunology, The Journal of Experimental Medicine, The Journal of Immunology and Clinical & Experimental Allergy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.